Fingerprint
Dive into the research topics of 'Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
B. Beuselinck*, P. Wolter, A. Karadimou, R. Elaidi, H. Dumez, A. Rogiers, T. Van Cann, L. Willems, J. J. Body, J. Berkers, H. Van Poppel, E. Lerut, P. Debruyne, R. Paridaens, P. Schöffski
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review